Miguel Lanaspa

As a pediatrician with a strong clinical research background in tropical settings, my research interest is focused on infectious diseases with high mortality burden on pediatric populations, particularly malaria and respiratory infections. My research activities aim at determining the healthy respiratory microbiome in children as a key step to design preventive tools against pediatric pneumonia, and at designing a birth cohort in a tropical setting to obtain a comprehensive picture of early-life and first years determinants of pediatric health outcomes.

1. Lanaspa M, Bassat Q, Medeiros MM, Munoz-Almagro C. Respiratory microbiota and lower respiratory tract disease. Expert review of anti-infective therapy 2017; 15(7): 703-11.
2. Silterra J, Gillette MA, Lanaspa M, et al. Transcriptional Categorization of the Etiology of Pneumonia Syndrome in Pediatric Patients in Malaria-Endemic Areas. J Infect Dis 2017; 215(2): 312-20.
3. Valim C, Ahmad R, Lanaspa M, et al. Responses to Bacteria, Virus and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia. American journal of respiratory and critical care medicine 2015.
4. Lanaspa M, O’Callaghan-Gordo C, Machevo S, et al. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2015; 21(11): 1018 e9- e15.
5. RTS,S CTP, Agnandji ST, Lell B, et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. The New England journal of medicine 2012; 367(24): 2284-95.